Please confirm that you would like to log out of Medscape.
If you log out, you will be required to enter your username and password the next time you visit.
Log outCancel
Exelixis Drug Improves Overall Survival in Liver Cancer PatientsExelixis Inc's drug to treat a type of liver cancer improved overall survival in patients in a late-stage study that prompted an independent expert group to recommend no further trial, sending the company's shares soaring 31%.
Should Doctors Embrace or Reject Alternative Treatments?More consumers are using complementary and alternative treatments, and medical centers are adding nontraditional therapies. Should doctors embrace or reject these treatments?
